Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mosconi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patientsM Mandalà, M Reni, S Cascinu, et al.
British Journal of Cancer|October 17, 2003
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancerF Graziano, D Santini, E Testa, et al.
Tumori|February 24, 2001
The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trialS Mosconi, S Cascinu, A Zaniboni, et al.
Cancer Chemotherapy and Pharmacology|December 15, 2015
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinomaS Cereda, M Milella, S Cordio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogramF Pietrantonio, R Miceli, L Rimassa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2014
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancerE Bajetta, I Floriani, M Di Bartolomeo, et al.
ESMO Open|August 15, 2021
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter surveyG Orsi, M Di Marco, A Cavaliere, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patientsM Mandalà, M Reni, S Cascinu, et al.
British Journal of Cancer|October 17, 2003
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancerF Graziano, D Santini, E Testa, et al.
Tumori|February 24, 2001
The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trialS Mosconi, S Cascinu, A Zaniboni, et al.
Cancer Chemotherapy and Pharmacology|December 15, 2015
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinomaS Cereda, M Milella, S Cordio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogramF Pietrantonio, R Miceli, L Rimassa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2014
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancerE Bajetta, I Floriani, M Di Bartolomeo, et al.
ESMO Open|August 15, 2021
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter surveyG Orsi, M Di Marco, A Cavaliere, et al.
Pageof 2